Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia

Genome-wide DNA methylation is predictive of outcome in juvenile myelomonocytic leukemia

Juvenile myelomonocytic leukemia (JMML) is an aggressive disease with limited options for treatment. Here, the authors utilize DNA methylation based subgroups in JMML to predict clinical outcome.

Bibliographic Details
Main Authors:	Elliot Stieglitz, Tali Mazor, Adam B. Olshen, Huimin Geng, Laura C. Gelston, Jon Akutagawa, Daniel B. Lipka, Christoph Plass, Christian Flotho, Farid F. Chehab, Benjamin S. Braun, Joseph F. Costello, Mignon L. Loh
Format:	Article
Language:	English
Published:	Nature Portfolio 2017-12-01
Series:	Nature Communications
Online Access:	https://doi.org/10.1038/s41467-017-02178-9

Similar Items

Molecular and phenotypic diversity of <I>CBL</I>-mutated juvenile myelomonocytic leukemia
by: Anna Hecht, et al.
Published: (2020-12-01)

Gene mutations do not operate in a vacuum: the increasing importance of epigenetics in juvenile myelomonocytic leukemia
by: Christian Flotho
Published: (2019-03-01)

Juvenile myelomonocytic leukemia: Molecular pathogenesis informs current approaches to therapy & hematopoietic cell transplantation
by: Mignon Lee-cheun Loh, et al.
Published: (2014-03-01)

THE INTERFACE OF EPIGENETICS AND ENERGY METABOLISM IN JUVENILE MYELOMONOCYTIC LEUKEMIA
by: Zoé Wehbe, et al.
Published: (2023-12-01)

Epigenetic dysregulation of the erythropoietic transcription factor KLF1 and the β-like globin locus in juvenile myelomonocytic leukemia
by: Silvia Fluhr, et al.
Published: (2017-08-01)

Induced Pluripotent Stem Cells to Model Juvenile Myelomonocytic Leukemia: New Perspectives for Preclinical Research
by: Zeinab Wehbe, et al.
Published: (2021-09-01)

LNK/<i>SH2B3</i> as a novel driver in juvenile myelomonocytic leukemia
by: Astrid Wintering, et al.
Published: (2023-12-01)

Clinical parameter-based prediction of DNA methylation classification generates a prediction model of prognosis in patients with juvenile myelomonocytic leukemia
by: Takahiro Imaizumi, et al.
Published: (2022-08-01)

P985: CLL-1 IS AN ADOPTIVE IMMUNOTHERAPY TARGET IN JUVENILE MYELOMONOCYTIC LEUKEMIA
by: Juwita Huebner, et al.
Published: (2023-08-01)

P998: TRETINOIN AND CALCITRIOL ENHANCE TREATMENT REGIMENS FOR JUVENILE MYELOMONOCYTIC LEUKEMIA IN EX VIVO DRUG SENSITIVITY ASSAYS
by: Elliot Stieglitz, et al.
Published: (2023-08-01)

Mutations in the let-7 binding site - a mechanism of RAS activation in juvenile myelomonocytic leukemia?
by: Doris Steinemann, et al.
Published: (2010-09-01)

Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia
by: Charlotte M. Niemeyer, et al.
Published: (2015-01-01)

The long non-coding RNA landscape in juvenile myelomonocytic leukemia
by: Mattias Hofmans, et al.
Published: (2018-11-01)

RAS-pathway mutation patterns define epigenetic subclasses in juvenile myelomonocytic leukemia
by: Daniel B. Lipka, et al.
Published: (2017-12-01)

How a rare pediatric neoplasia can give important insights into biological concepts: a perspective on juvenile myelomonocytic leukemia
by: Christian Flotho, et al.
Published: (2007-11-01)

ILLUSTRATION OF CLONAL ARCHITECTURE IN JUVENILE MYELOMONOCYTIC LEUKEMIA BY TARGETED SINGLE-CELL DNA SEQUENCING
by: Foued Ghanjati, et al.
Published: (2023-12-01)

Molecular basis of juvenile myelomonocytic leukemia
by: Andrica C.H. de Vries, et al.
Published: (2010-02-01)

Juvenile myelomonocytic leukemia: Rare case
by: Hadi Geylan, et al.
Published: (2018-07-01)

P1000: JUVENILE MYELOMONOCYTIC LEUKEMIA (JMML) INHIBITS T CELL PROLIFERATION VIA THE ECTONUCLEOTIDASE CD39 AND THE PURINERGIC NETWORK
by: Jovana Rajak, et al.
Published: (2023-08-01)

Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia
by: Mattias Hofmans, et al.
Published: (2021-02-01)

Phenotypic and genotypic characterisation of juvenile myelomonocytic leukaemia
by: Louka, E
Published: (2018)

Molecular Targets for the Treatment of Juvenile Myelomonocytic Leukemia
by: Xiaoling Liu, et al.
Published: (2012-01-01)

The role of splenectomy in children with juvenile myelomonocytic leukemia
by: Emel Ozyürek, et al.
Published: (2007-04-01)

Juvenile Myelomonocytic Leukemia: A diagnostic dilemma
by: Nidhi Srivastava, et al.
Published: (2022-01-01)

JUVENILE MYELOMONOCYTIC LEUKEMIA SINGLE CENTER EXPERIENCE
by: Yunus Murat Akcabelen, et al.
Published: (2021-11-01)

Long-term serial xenotransplantation of juvenile myelomonocytic leukemia recapitulates human disease in Rag2−/−γc−/− mice
by: Christopher Felix Krombholz, et al.
Published: (2016-05-01)

Generation of a human Juvenile myelomonocytic leukemia iPSC line, CHOPi001-A, with a mutation in CBL
by: Alyssa L. Gagne, et al.
Published: (2018-08-01)

ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT
by: Mark Hartmann, et al.
Published: (2023-12-01)

Mutation analysis of the BRAF oncogene in juvenile myelomonocytic leukemia
by: Andrica C.H. de Vries, et al.
Published: (2007-11-01)

JUVENILE MYELOMONOCYTIC LEUKEMIA WITH TELOMERE SHORTENING: CASE REPORT
by: Anita Frisanco Oliveira, et al.
Published: (2023-12-01)

P1072: NATURAL HISTORY OF JUVENILE MYELOMONOCYTIC LEUKEMIA
by: W. Yang, et al.
Published: (2022-06-01)

Heterogeneous disease-propagating stem cells in juvenile myelomonocytic leukemia
by: Louka, E, et al.
Published: (2021)

CircRNAs Dysregulated in Juvenile Myelomonocytic Leukemia: CircMCTP1 Stands Out
by: Anna Dal Molin, et al.
Published: (2021-01-01)

Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1
by: Doris Steinemann, et al.
Published: (2010-02-01)

S206: ONCO-FETAL REPROGRAMMING DRIVES HIGH-RISK JUVENILE MYELOMONOCYTIC LEUKEMIA, WHICH CAN BE TARGETED BY ANTI-CD52 TREATMENT
by: Mark Hartmann, et al.
Published: (2023-08-01)

Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia
by: Sarah Abu Kar, et al.
Published: (2013-01-01)

Refining risk stratification to improve prognosis in juvenile myelomonocytic leukemia
by: Jenna L. Nunn, et al.
Published: (2024-05-01)

Leucemia mielomonocítica juvenil: relato de caso Juvenile myelomonocytic leukaemia: case report
by: Mariela G. Farias, et al.
Published: (2010-01-01)

Use of Rapamycin in a Patient With Juvenile Myelomonocytic Leukemia: A Case Report
by: Shivani Y. Upadhyay MD, et al.
Published: (2017-09-01)

Juvenile Myelomonocytic Leukemia in Turkey: A Retrospective Analysis of Sixty-five Patients
by: Özlem Tüfekçi, et al.
Published: (2018-02-01)